Investigation of a wide spectrum of genetic and molecular PCa markers in setting of "liquid biopsy" (PCA3, DLX1, HOXC6, TMPRSS2:ERG, NBS1, HOXB13, G84E, RS 188140481).
Imaging markers
Apparent diffusion coefficient of multiparametric MRI in detection of clinically significant prostate cancer and differentiation of the Gleason score of the tumor.
Renal cell carcinoma
Molecular markers
Urine, blood serum and tissue expression of microRNA-15a as diagnostic, prognostic and prediction tumor marker of RCC.
Blood serum expression of microRNA-508-3p as diagnostic marker of RCC.
Imaging markers
Apparent diffusion coefficient of diffusion-weighted images of MRI as marker for differentiation of benign renal tumors, RCC and Fuhrman grades of differentiation.
Apparent diffusion coefficient of diffusion-weighted images of MR and resistance index of USG as an imaging biomarkers in prediction of the blood loss during nephrectomy due to RCC after embolization of renal artery.
Prognostication of chronic kidney disease development in patients with RCC using apparent diffusion coefficient of MRI.
Signal intensity of multiphase CT as marker for differentiation of benign renal tumors, RCC and Fuhrman grades of differentiation.
Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response
Radiogenomic studies
Investigation of associations between cross-sectional imaging features of RCC and urine expression levels of miR-15a.
Bladder cancer
Molecular markers
VEGF, TNF-α and TNF- β as diagnostic molecular markers of BC and their relationship with the degree of tumor neoplasia.